HIGHLIGHTS
- who: Doris Helbig from the Oregon Health and Science University, United States have published the Article: Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas, in the Journal: (JOURNAL)
- future: In patients with advanced stage PDS treated with CPI further investigation of predictors is still needed.
SUMMARY
Pleomorphic dermal sarcomas (PDS) are rare neoplasms of the skin with a mesenchymal (fibroblastic) lineage differentiation, arising in UV-exposed locations, typically diagnosed in elderly male individuals. The main difference is that AFX are confined to the dermis whereas PDS involves distinct portions . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.